PT  - JOURNAL ARTICLE
AU  - Ding, Hao
AU  - Nasseroleslami, Bahman
AU  - Mirzac, Daniela
AU  - Volkmann, Jens
AU  - Deuschl, Gunter
AU  - Groppa, Sergiu
AU  - Muthuraman, Muthuraman
TI  - Re-emergent Tremor during stable posture in Parkinson’s Disease: Evidence of Pathological Beta and Prokinetic Gamma Activity
AID  - 10.1101/2023.08.23.23294492
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.08.23.23294492
4099  - http://medrxiv.org/content/early/2023/08/24/2023.08.23.23294492.short
4100  - http://medrxiv.org/content/early/2023/08/24/2023.08.23.23294492.full
AB  - Re-emergent tremor (RET) during stable posture in Parkinson’s disease (PD) is characterized as a continuation of resting tremor (RT) and is often highly therapy refractory. The pathophysiology of both RT and RET is linked to deficits in cerebello-cortical circuits and dopaminergic depletion. However, it remains unclear how these two types of tremors differ functionally. The aim of this study is to examine the differences in brain activity between RT and RET in PD, as well as to investigate the relationship between neuronal oscillatory activity, in PD tremor phenotype patients.Forty PD patients (25 males, mean age 66.78 ± 5.03 years) and 40 age- and sex-matched healthy controls were assessed. 256 channel HD-EEG and EMG signals were recorded while the participants extended their hands against gravity. Tremor was recorded in both L-dopa ON and OFF for PD patients and mimicked by healthy controls. Coherent sources of EEG-EMG were located using beamforming technique, and information flow between different sources was estimated using time-resolved partial-directed coherence. Cross-frequency coupling (CFC) was then used to analyze the association between tremor frequency and neuronal oscillatory activity.Under L-dopa administration, coherent sources referenced to the tremor frequency revealed differences in brain activity between RT and RET in the premotor cortex and cerebellum of PD patients, which were similar to those observed in healthy controls. However, PD patients exhibited an additional source location in the primary sensorimotor cortex. Withdrawal of L-dopa led to coherent sources being observed in the supplementary motor area and subthalamic nucleus. Furthermore, L-dopa was found to suppress the strength of connections between these coherent sources and modulate the tremor-associated beta and gamma frequency, leading to a decrease in beta power and an increase in gamma power.The findings of this study reveal discernible neural activity patterns during resting and re-emergent tremors. In patients with PD, the primary sensorimotor cortex plays a primordial role as the exclusive source of activity involved in the generation of RET. It shows a significant amount of co-activation within the network involving the premotor areas and cerebellum, and its activation accounts for the discrepancy in tremor phenotypes. Moreover, the oscillatory neuronal responses involve pathological beta and prokinetic gamma activity alterations that are highly specific to tremor phenotypes. These peculiarities play an essential role in our understanding of tremor phenomena and its therapeutic modulation by dopamine medication or deep brain stimulation, which could specifically target the tremor- and motor-control-related pathological beta and prokinetic gamma oscillations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the German Research Foundation (DFG): SFB-TRR-295 (to M.M.), MU 4354/1-1(to M.M.) and the and the Fondazione Grigioni per il Morbo di Parkinson by IUI.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics commitee of medical faculty in university of Kiel gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors